HPHAHeidelberg PharmaHPHA info
$2.27info-3.96%24h
Global rank19465
Market cap$105.56M
Change 7d-8.02%
YTD Performance-41.08%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Heidelberg Pharma (HPHA) Stock Overview

    Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. Its lead product candidate is HDP-101, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. The company is developing HDP-102 for the treatment of non-Hodgkin lymphoma; HDP-103, an ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for the treatment of gastrointestinal tumors; HDP-XX for the treatment of solid/hematological tumors; MGTA-ATACs for HSCs, conditioning programs to treat blood cancers/genetic diseases; and TAK-ATACs for oncology. It is also developing TLX250-CDx, a diagnostic antibody for diagnosing renal cancer that is in Phase III trials; urothelial carcinoma or bladder cancer, which is in Phase II study; and triple-negative breast cancer that is in Phase II study. In addition, the company develops TLX250 (girentuximab), a diagnostic antibody, which is in Phase II study for patients with advanced clear cell renal cell carcinoma; RHB-107, an oral serine protease inhibitor that is in Phase II/III study to treat COVID-19, as well as for the treatment of advanced cholangiocarcinoma; and LH011 for pancreatic cancer. It has licensing agreement and strategic partnership with Huadong Medicine Co., Ltd. for the development and commercialization rights for HDP-101 and HDP-103 in Asia. The company was formerly known as Wilex AG and changed its name to Heidelberg Pharma AG in October 2017. Heidelberg Pharma AG was founded in 1997 and is based in Ladenburg, Germany.

    HPHA Stock Information

    Symbol
    HPHA
    Address
    Gregor-Mendel-Strasse 22Ladenburg, 68526Germany
    Founded
    -
    Trading hours
    9:00 AM - 5:30 PM CET
    Website
    https://heidelberg-pharma.com
    Country
    🇩🇪 Germany
    Phone Number
    49 6203 1009 0

    Heidelberg Pharma (HPHA) Price Chart

    -
    Value:-

    Heidelberg Pharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.27
    N/A
    Market Cap
    $105.56M
    N/A
    Shares Outstanding
    46.60M
    N/A
    Employees
    101.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org